Home Page

DUBLIN, May 5, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment, by Product, by Application, by Geography, Reimbursement, Selection Criteria and Buying Cycle" report to their offering.

Medical robots are increasingly being adopted by hospitals and patients across the globe, particularly in the U.S. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the adoption of medical robots.

This report provides qualitative assessment of medical robots (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy) in terms of prices of different types of robots, price variation by application & geography, reimbursements of medical robots, buying cycle, financing options available to the end-users to access the technology, price wars among market players, marketing & promotional strategies focused by the vendors, and cost-benefit assessment based on research studies and expert opinions.

The application and technology form the two important components that guide the final pricing of a medical robot. For instance, the surgical robots for laparoscopic applications are most expensive as compared to surgical robots for other applications. In addition, technological variation further creates price variation, an example for which is the named Zeno R25 (rehabilitation robot by RoboKind) which is expected to be launched in retail space at a price tag of USD 2,700. To cut the cost in R25, the manufacturers reduced the number of motors below the waist from 12 to three while still allowing the robot to walk and turn.

Medical Robotics being a highly sophisticated technology showcases slow adoption due to economic hurdles. However, medical robots have become an extremely popular topic over the last few years. Thus, the cost-benefit assessment has taken center stage in the industry and is dominating almost every conversation and headlining several conferences in the field of robotics. The report has provided cost-benefit assessment covering cost benefit studies and industry opinion.

The section provides a guideline to the stakeholders in understanding the investment structure and the cost-savings achieved through the use of each type of robot. To increase the access to this expensive technology, manufacturers have been offering varied financing options to the healthcare providers. Some of the options include leasing, pay-per-use, bundled payments, rental agreements, and expanded payment terms, among others.

Key Topics Covered:

1 Introduction

2 Medical Robots: Pricing Landscape 2.1 Introduction 2.2 Indicative Price List 2.2.1 Surgical Robots 2.2.2 Rehabilitation Robots 2.2.3 Non-Invasive Radiosurgery Systems (Robot-Based) 2.2.4 Hospital & Pharmacy Robots 2.3 Price Variation Assessment 2.3.1 By Application 2.3.1.1 Surgical Robots 2.3.1.2 Rehabilitation Robots 2.3.1.3 Non-Invasive Radiosurgery Systems (Robot-Based) 2.3.2 By Geography 2.3.2.1 Surgical Robots 2.3.2.2 Hospital & Pharmacy Robots 2.3.2.3 Non-Invasive Radiosurgery Systems (Robot-Based)

3 Expected Price War: Surgical Robots Market (Intuitive vs Competition)

4 Medical Robots: Reimbursement Landscape, By Region 4.1 Surgical Robots 4.2 Rehabilitation Robots 4.3 Non-Invasive Radiosurgery Systems (Robot-Based)

5 Medical Robots: Major Price Determinants

6 Medical Robots: Financing Options Assessment 6.1 Surgical Robots 6.2 Rehabilitation Robots 6.3 Non-Invasive Radiosurgery Systems (Robot-Based) 6.4 Hospital & Pharmacy Robots

7 Medical Robots: Key Influncers & Decision-Makers

7.1 Surgical Robots

7.2 Rehabilitation Robots

7.3 Non-Invasive Radiosurgery Systems (Robot-Based)

7.4 Hospital & Pharmacy Robots

8 Medical Robots: Key Selection Criteria for End-User

9 Medical Robots: Buying Cycle Assessment

10 Medical Robots: Marketing & Promotions Strategies Adopted By Vendors

11 Cost-Benefit Assessment (Based on Research Studies & Expert Opinions)

11.1 Surgical Robots

11.1.1 Cost-Benefit Studies

11.1.1.1 A Da Vinci Robot System Can Make Sense for A Mature Laparoscopic Prostatectomy Program

11.1.1.2 Robot-Assisted Surgery Compared With Open Surgery and Laparascopic Surgery: Clinical Effectiveness and Economic Analyses

11.1.2 Industry Speaks

11.2 Rehabilitation Robots

11.2.1 Economic Impact of Rehabilitation Robots Vis-À-Vis Disease Burden

11.2.2 Cost-Benefit Studies

11.2.2.1 an Economic Analysis of Robot-Assisted Therapy Fro Long-Term Upper-Limb Imparement After Stroke

11.2.3 Industry Speaks

11.3 Non-Invasive Radiosurgery Systems (Robot-Based)

11.3.1 Cost-Benefit Studies

11.3.1.1 A Comparative Study of Gamma Knife Radiosurgery Versus Open Surgery for Intracranial Pathology

11.3.1.2 Outcomes and Cost-Effectiveness of Gamma Knife Radiosurgery and Whole-Brain Radiotherapy for Multiple Metastatic Brain Tumors

11.3.1.3 Cost-Effectiveness Analysis of A Randomized Study Comparing Radiosurgery With Radiosurgery and Whole Brain Radiation Therapy in Patients With 1 to 3 Brain Metastases

11.3.1.4 Cyberknife for Prostrate Cancer: is It Cost-Effective

11.3.1.5 Tomotherapy, Gamma Knife, and Cyberknife Therapies for Patients With Tumors of the Lung, Central Nervous System, Or Intra-Abdomen: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness

11.3.2 Industry Speaks

11.4 Hospital & Pharmacy Robots

11.4.1 Cost-Benefit Studies

11.4.1.1 Impact of Robotic Dispensing Machines in German Pharmacies on Business Performance Indicators

11.4.1.2 Recent Trends in the Usage of Robotics in Pharmacy

11.4.1.3 Cover Story - Rise of Machines

11.4.1.4 Automated Medication Dispensing Systems : A Review of the Clinical Benefits, Harms, and Cost-Effectiveness

11.4.2 Industry Speaks

Companies Mentioned

- Elekta AB

- Hocoma AG

- Intuitive Surgicals

- Mazor Robotics

- Rewalk

- Varian Medical Systems

For more information visit http://www.researchandmarkets.com/research/n89cwk/medical_robots

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets